Ligand · 8V7
8V7 · 2-[4-(propan-2-yl)-4H-1,2,4-triazol-3-yl]-N-(pyridin-2-yl)-1,3-thiazole-4-carboxamide
8V7, 2-[4-(propan-2-yl)-4H-1,2,4-triazol-3-yl]-N-(pyridin-2-yl)-1,3-thiazole-4-carboxamide (C14 H14 N6 O S, 314.4 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within…
- Component
- 8V7
- Formula
- C14 H14 N6 O S
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
8V7 in 2 structures; the first of them:
- 5V24 · Structure-based drug design of novel ASK1 inhibitors using a fully integrated lead… · 8V7 A1000 · binds LEU686, GLY687, LYS688, GLY689, VAL694, ALA707, LYS709, VAL738 and 10 more
- 5V24 · Structure-based drug design of novel ASK1 inhibitors using a fully integrated lead… · 8V7 A1000 · binds LEU686, GLY687, LYS688, GLY689, VAL694, ALA707, LYS709, MET754 and 8 more
Residues it binds most
GLY 4, VAL 4, ASP 4, LEU 4, LYS 4, ALA 4, GLN 4, GLU 4, MET 4, SER 4 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.